Exponent, Inc. (EXPO)
NASDAQ: EXPO · Real-Time Price · USD
60.22
-0.61 (-1.00%)
Jun 29, 2026, 1:02 PM EDT - Market open

Company Description

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally.

The company operates in two segments, Engineering and Other Scientific, and Environmental and Health.

It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering.

The company also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences.

In addition, it provides proactive and reactive product safety, litigation support, and technical, regulatory services.

It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors.

The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998.

The company was founded in 1967 and is headquartered in Menlo Park, California.

Exponent, Inc.
Exponent logo
Country United States
Founded 1967
IPO Date Aug 17, 1990
Industry Engineering & Construction
Sector Industrials
Employees 1,013
CEO Catherine Corrigan

Contact Details

Address:
149 Commonwealth Drive
Menlo Park, California 94025
United States
Phone 650 326 9400
Website exponent.com

Stock Details

Ticker Symbol EXPO
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year February - January
Reporting Currency USD
CIK Code 0000851520
CUSIP Number 30214U102
ISIN Number US30214U1025
Employer ID 77-0218904
SIC Code 8742

Key Executives

Name Position
Dr. Catherine Ford Corrigan P.E., Ph.D. Chief Executive Officer and Director
Richard L. Schlenker Jr. Executive Vice President and Corporate Secretary
Dr. Maureen T. F. Reitman F.S.P.E., P.E., Sc.D. Group Vice President
Dr. Joseph Rakow Ph.D. Group Vice President
Dr. Joseph Sala Ph.D. Group Vice President
Dr. John D. Pye P.E., Ph.D. President
Dr. Bernard Ross P.E., Ph.D. Co-Founder, Chairman Emeritus and Principal Engineer
Eric R. Anderson Chief Financial Officer

Latest SEC Filings

Date Type Title
Jun 15, 2026 144 Filing
Jun 10, 2026 8-K Current Report
May 26, 2026 144 Filing
May 19, 2026 144 Filing
May 15, 2026 144 Filing
May 14, 2026 SCHEDULE 13G/A Filing
May 13, 2026 144 Filing
May 13, 2026 144 Filing
May 8, 2026 10-Q Quarterly Report
Apr 30, 2026 8-K Current Report